Tag: Hatch-Waxman Act
Bioequivalence Studies: What FDA Requires Manufacturers to Prove for Approval
May 23, 2026 / 0 Comments
Understand the FDA's strict bioequivalence requirements for generic drug approval. Learn about the 80-125 rule, ANDA submissions, biowaivers, and common pitfalls to avoid.
READ MORE
Cost Comparison: Authorized Generics vs First-to-File Generics
Nov 21, 2025 / 12 Comments
Authorized generics and first-to-file generics can drastically affect drug prices. Learn how competition between them lowers costs for consumers and why knowing the difference can save you money on prescriptions.
READ MORERECENT POSTS
- Lung Transplant for Idiopathic Pulmonary Fibrosis: What to Expect, Timeline, Risks, Recovery
- Tamoxifen vs. Aromatase Inhibitors: Choosing the Right Hormone Therapy for Breast Cancer
- Vinpocetine and Cancer: Prevention and Treatment Insights
- Atorvastatin and Lupus: Benefits, Heart Risk Reduction, and Safe Use
- Pharmacist Legal Obligations for Generic Drug Substitution